GPAM and fatty liver disease: Consistent with the results obtained from the overexpression of GPAT1, GPAT1−/− mice showed remarkably lower amounts of hepatic TAG and DAG and were prevented from high-fat feeding-induced hepatic steatosis and hepatic insulin resistance [55].